Sporamin suppresses growth of human esophageal squamous cell carcinoma cells by inhibition of NFκB via an AKTindependent pathway.
Mol Med Rep
; 16(6): 9620-9626, 2017 Dec.
Article
em En
| MEDLINE
| ID: mdl-29039512
ABSTRACT
The aim of the present study was to determine whether sporamin, a trypsin inhibitor, suppresses the growth of human esophageal squamous cell carcinoma (ESCC) cells in vitro. Sporamin treatment led to the suppression of viability and proliferation of human ESCC cell lines, EC9706 and EC109, as determined by MTT and [3H] thymidine incorporation assays, respectively. Flow cytometry and fluorescence microscopy demonstrated that sporamin significantly induced apoptosis in EC9706 and EC109 cells. Western blotting demonstrated that sporamin downregulated the expression of Bcl2 and Bcl2 like 1, and upregulated the expression of Bcl2associated X in EC9706 and EC109 cells. In addition, marked inhibition of nuclear factor (NF)κB activation was observed in sporamintreated EC9706 and EC109 cells by an electrophoretic mobility shift assay. Sporamin treatment also resulted in reduced expression levels of phosphorylated (p)NFκB inhibitor α and nuclear NFκB p65. However, the expression levels of pprotein inase (AKT) and its downstream target, pp70 S6 kinase, were not markedly altered following sporamin treatment. In conclusion, sporamin may suppress the growth of human ESCC cells via NFκBdependent and AKTindependent mechanisms and may act as a promising natural therapeutic agent for the treatment of human ESCC.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Inibidores de Proteases
/
Neoplasias Esofágicas
/
Carcinoma de Células Escamosas
/
Transdução de Sinais
/
NF-kappa B
/
Proteínas Proto-Oncogênicas c-akt
Limite:
Humans
Idioma:
En
Revista:
Mol Med Rep
Ano de publicação:
2017
Tipo de documento:
Article